Europe set for milestone PSA screening debate
This article was originally published in Clinica
Executive Summary
Experts preparing to discuss prostate cancer screening policy at this month's European Association of Urology (EAU) congress are arming themselves with data that show both dramatic increases in incidence and significant reductions in mortality from the disease. They believe this may be attributable to early diagnosis.